update

Cango Inc. Announces March 2026 Operational Update; Strategically Optimizing Mining Fleet and Improving Production Economics

DALLAS, April 8, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG), a leading Bitcoin miner leveraging its global operations to develop…

2 months ago

NYSE Content Update: HumanX to Ring Remote Bell with 350+ Speakers On Site

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 8, 2026 /PRNewswire/ -- The New York…

2 months ago

NYSE Content Update: Starfish Space Adds Over $100 Million in Funding to Boost Growth

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 7, 2026 /PRNewswire/ -- The New York…

2 months ago

NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 6, 2026 /PRNewswire/ -- The New York…

2 months ago

NYSE Content Update: Artemis II Lifts Off, Takes Crew Toward Moon for First Time since 1972

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 2, 2026 /PRNewswire/ -- The New York…

2 months ago

NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 1, 2026 /PRNewswire/ -- The New York…

3 months ago

Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update

– Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD – –…

3 months ago

NYSE Content Update: A Sweet Time at the NYSE as Hershey Hosts its Investor Day

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 31, 2026 /PRNewswire/ -- The New York…

3 months ago

NYSE Content Update: Koppers to Ring Closing Bell for 20th Listing Anniversary

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 30, 2026 /PRNewswire/ -- The New York…

3 months ago

Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology

Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World…

3 months ago